life sciences
Early-stage study gives hope for rare and fatal neurodegenerative condition
August 11, 2017Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
Ending the era of $100,000 cancer drugs
August 11, 2017Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical
Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
Heart failure mortality rates fall across England and Wales, national audit finds
August 11, 2017Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical
Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …
Continuous manufacturing: Upgrading the supply chain to meet rising demand
August 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing continuous manufacturing, life sciences, manufacturing, medicine, pharma, pharmaceutical
Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. …
Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind
August 10, 2017Sales and Marketing Roivant, SoftBank, biotech, life sciences, medicine, pharma, pharmaceuticals
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …
Bayer’s liver cancer drug availability spreads to UK with NICE approval
August 10, 2017Sales and Marketing Bayer, Cancer, NICE, Nexavar, life sciences, liver cancer, pharma, pharmaceutical
NICE has announced that it has given final appraisal recommending Bayer’s Nexavar (sorafenib) for the treatment of advanced hepatocellular carcinoma …
One in twelve US doctors accepted opioid-related payments from pharma, finds study
August 10, 2017Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical
In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …
Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug
August 10, 2017Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical
Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …
Pioneering immunotherapy halts progression of type 1 diabetes
August 10, 2017Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical
In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …
FDA awards orphan status to new brain cancer vaccine
August 9, 2017Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals
The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …
Chemotherapy can spread breast cancer to lungs, study finds
August 9, 2017Research and Development Cancer, breast cancer, life sciences, lung cancer, pharma, pharmaceutical
Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight …
Merck scores expanded NICE recommendation in head, neck and oral cancer
August 8, 2017Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals
Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …
NICE recommends plaque psoriasis contender for NHS use
August 8, 2017Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis
The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …
Stomach acid drugs do not increase Alzheimer’s risk, study confirms
August 7, 2017Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors
A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …
FDA fast tracks Valneva’s Lyme disease vaccine
August 7, 2017Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial
French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …
